Cost‐effectiveness of a risk‐based secondary screening programme of type 2 diabetes

E-ISSN： 1099-0895|32|7|710-729

ISSN： 1520-7552

Source： DIABETES/METABOLISM: RESEARCH AND REVIEWS (ELECT), Vol.32, Iss.7, 2016-10, pp. : 710-729

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The burden of type 2 diabetes in Serbia and the cost-effectiveness of its management

By Bjegovic Vesna Terzic Zorica Marinkovic Jelena Lalic Nebojsa Sipetic Sandra Laaser Ulrich

The European Journal of Health Economics, Vol. 8, Iss. 2, 2007-06 ,pp. : 97-103

Springer Publishing Company

Access to resources Recommend Favorite

Cost‐effectiveness analysis of adding pharmacists to primary care teams to reduce cardiovascular risk in patients with Type 2 diabetes: results from a randomized controlled trial

DIABETIC MEDICINE, Vol. 32, Iss. 7, 2015-07 ,pp. : 899-906

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical relevance and cost‐effectiveness of HLA genotyping in children with Type 1 diabetes mellitus in screening for coeliac disease in the Netherlands

DIABETIC MEDICINE, Vol. 32, Iss. 6, 2015-06 ,pp. : 834-838

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of the cost-effectiveness of insulin glargine versus NPH insulin for the treatment of type 2 diabetes in the UK

By McEwan Phil Poole Chris D. Tetlow Tony Holmes Paul Currie Craig J.

Current Medical Research and Opinion, Vol. 23, Iss. 1, 2007-02 ,pp. : 21-31

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness of liraglutide versus rosiglitazone, both in combination with glimepiride in treatment of type 2 diabetes in the US

By Lee W.C. Conner C. Hammer M.

Current Medical Research and Opinion, Vol. 27, Iss. 5, 2011-05 ,pp. : 897-906

Informa Healthcare

Access to resources Recommend Favorite